A rare collision tumor comprising intracystic papillary neoplasm associated with adenocarcinoma and angiosarcoma in the gallbladder
Article information
Korean J Intern Med. 2020;35(3):732-733
1Department of Radiology, College of Medicine, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon, Korea
2Department of Internal Medicine, College of Medicine, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon, Korea
3Department of Surgery, College of Medicine, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon, Korea
4Department of Pathology, College of Medicine, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon, Korea
Correspondence to Jong Ok Kim, M.D. Tel: +82-42-220-9611 Fax: +82-42-220-9843 E-mail:
jkim@catholic.ac.kr
Received 2018 November 2; Revised 2018 November 13; Accepted 2018 November 21.
A 78-year-old woman who had been diagnosed with a gallbladder polyp presented to the emergency department with epigastric pain and dizziness. Nineteen months prior to presentation, a 5 mm-sized enhancing polyp of the gallbladder was first detected on an abdominal computed tomography (CT) scan (). Seven months prior, the polyp had grown to 2.5 cm (). One month prior, the polyp had grown to 3.5 cm, and focal low-density nodular lesions with pericholecystic infiltration were newly detected (). At the initial diagnosis, the patient had refused a cholecystectomy. On presentation, physical examination revealed conjunctival pallor and epigastric tenderness. The patient denied any history of hematochezia or hematemesis. A complete blood count revealed anemia (hemoglobin level, 7.8 g/dL). The patient’s blood chemistries including liver function test were normal. CT of the abdomen disclosed an extremely distended and edematous gallbladder with a large hematoma in the lumen (). Ultrasound-guided percutaneous gallbladder drainage was first performed, followed by laparoscopic cholecystectomy.
Gallbladder cancer in a 78-year-old woman. (A) Initial enhanced computed tomography (CT) image showing focal wall thickening (arrowhead) and a 5-mm enhancing polyp (arrow) in the fundus of the gallbladder. (B) Enhanced CT image obtained after 12 months showing that the small polyp (arrow) had grown to a 2.5-cm enhancing polypoid mass. (C) Enhanced CT image obtained after 18 months showing that the polypoid mass (arrow) had further enlarged, and focal low density nodular lesions with pericholecystic infiltration were observed (arrowhead). (D) Enhanced CT image obtained after 19 months showing the distended gallbladder with a hyperdense blood clot (*) in the lumen, diffuse edematous wall thickening, and decreased enhancement of the polypoid mass (arrow).
The gallbladder showed polypoid masses underlying the hemorrhagic mass, measuring 4 × 3 × 2 cm (). The tumor was located 3 cm away from the resection margin. Pathologically, an intracystic papillary neoplasm (ICPN) with focal adenocarcinoma (3.5 × 2.0 × 0.9 cm) ( and ) and angiosarcoma (2.0 × 2.0 × 0.3 cm) () was diagnosed. The ICPN and angiosarcoma were immunopositive for cytokeratin and CD31, respectively ( and ). Three months after surgery, the patient is doing well without evidence of recurrence.
Gross and pathologic findings of intracystic papillary neoplasm associated with adenocarcinoma and angiosarcoma in the gallbladder. (A) A few polypoid masses with hemorrhagic ulcer in the gallbladder. (B) Intracystic papillary neoplasm showing complex papillary configuration, and the solid masses underlying the neoplasm with hemorrhage spreading from the lamina propria to the perimuscular connective tissue (H&E, ×70). (C) Adenocarcinomatous glands invading the muscular layer (H&E, ×60). (D) Angiosarcoma showing anastomosing blood vessels lined by atypical endothelial cells (H&E, ×120). (E) Intracystic papillary neoplasm showing immunohistochemical positivity for cytokeratin (×40). (F) Angiosarcoma showing immunohistochemical positivity for CD31 (×200).
Although ICPN is associated with invasive cancer, the prognosis is better than that of other gallbladder cancers. However, the prognosis of gallbladder angiosarcoma is poor, and the clinical presentation can be mistaken for that of acute cholecystitis. Precise early diagnosis using imaging techniques and pathological examination is important. To our knowledge, this is the only case of collision tumor with adenocarcinoma arising in ICPN and angiosarcoma in the gallbladder.
Written informed consents were obtained.
Article information Continued
Copyright © 2020 The Korean Association of Internal Medicine
Figure 1.
Gallbladder cancer in a 78-year-old woman. (A) Initial enhanced computed tomography (CT) image showing focal wall thickening (arrowhead) and a 5-mm enhancing polyp (arrow) in the fundus of the gallbladder. (B) Enhanced CT image obtained after 12 months showing that the small polyp (arrow) had grown to a 2.5-cm enhancing polypoid mass. (C) Enhanced CT image obtained after 18 months showing that the polypoid mass (arrow) had further enlarged, and focal low density nodular lesions with pericholecystic infiltration were observed (arrowhead). (D) Enhanced CT image obtained after 19 months showing the distended gallbladder with a hyperdense blood clot (*) in the lumen, diffuse edematous wall thickening, and decreased enhancement of the polypoid mass (arrow).
Figure 2.
Gross and pathologic findings of intracystic papillary neoplasm associated with adenocarcinoma and angiosarcoma in the gallbladder. (A) A few polypoid masses with hemorrhagic ulcer in the gallbladder. (B) Intracystic papillary neoplasm showing complex papillary configuration, and the solid masses underlying the neoplasm with hemorrhage spreading from the lamina propria to the perimuscular connective tissue (H&E, ×70). (C) Adenocarcinomatous glands invading the muscular layer (H&E, ×60). (D) Angiosarcoma showing anastomosing blood vessels lined by atypical endothelial cells (H&E, ×120). (E) Intracystic papillary neoplasm showing immunohistochemical positivity for cytokeratin (×40). (F) Angiosarcoma showing immunohistochemical positivity for CD31 (×200).